Literature DB >> 10471677

Evaluation of measurement sites for noninvasive blood glucose sensing with near-infrared transmission spectroscopy.

J J Burmeister1, M A Arnold.   

Abstract

Six putative measurement sites were evaluated for noninvasive sensing of blood glucose by first-overtone near-infrared spectroscopy. The cheek, lower lip, upper lip, nasal septum, tongue, and webbing tissue between the thumb and forefinger were examined. These sites were evaluated on the basis of their chemical and physical properties as they pertain to the noninvasive measurement of glucose. Critical features included the effective optical pathlength of aqueous material within the tissue and the percentage of body fat within the optical path. Aqueous optical paths of 5 mm are required to measure clinically relevant concentrations of glucose in the first-overtone region. All of the tested sites met this requirement. The percentage of body fat affects the signal-to-noise ratio of the measurement and must be minimized for reliable glucose sensing. The webbing tissue contains a considerable amount of fat tissue and is clearly the worse measurement site. All other sites possess substantially less fat, with the least amount of fat in tongue tissue. For this reason, the tongue provides spectra with the highest signal-to-noise ratio and is, therefore, the site of choice on the basis of spectral quality.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471677

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

1.  Hollow optical-fiber based infrared spectroscopy for measurement of blood glucose level by using multi-reflection prism.

Authors:  Saiko Kino; Suguru Omori; Takashi Katagiri; Yuji Matsuura
Journal:  Biomed Opt Express       Date:  2016-01-29       Impact factor: 3.732

2.  Microneedle-based automated therapy for diabetes mellitus.

Authors:  Puneet Khanna; Joel A Strom; John I Malone; Shekhar Bhansali
Journal:  J Diabetes Sci Technol       Date:  2008-11

Review 3.  Progress toward an in vivo surface-enhanced Raman spectroscopy glucose sensor.

Authors:  Olga Lyandres; Jonathan M Yuen; Nilam C Shah; Richard P VanDuyne; Joseph T Walsh; Matthew R Glucksberg
Journal:  Diabetes Technol Ther       Date:  2008-08       Impact factor: 6.118

4.  First step toward near-infrared continuous glucose monitoring: in vivo evaluation of antibody coupled biomaterials.

Authors:  Karolien Gellynck; Valérie Kodeck; Elke Van De Walle; Ken Kersemans; Filip De Vos; Heidi Declercq; Peter Dubruel; Lieven Vlaminck; Maria Cornelissen
Journal:  Exp Biol Med (Maywood)       Date:  2014-10-10

5.  Mid-Infrared Photoacoustic Detection of Glucose in Human Skin: Towards Non-Invasive Diagnostics.

Authors:  Jonas Kottmann; Julien M Rey; Markus W Sigrist
Journal:  Sensors (Basel)       Date:  2016-10-10       Impact factor: 3.576

Review 6.  Glucose biosensors in clinical practice: principles, limits and perspectives of currently used devices.

Authors:  Salvatore Andrea Pullano; Marta Greco; Maria Giovanna Bianco; Daniela Foti; Antonio Brunetti; Antonino S Fiorillo
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

7.  Spectral Methods for Response Enhancement of Microwave Resonant Sensors in Continuous Non-Invasive Blood Glucose Monitoring.

Authors:  Giovanni Buonanno; Adriana Brancaccio; Sandra Costanzo; Raffaele Solimene
Journal:  Bioengineering (Basel)       Date:  2022-04-04

8.  Enhancing the Accuracy of Non-Invasive Glucose Sensing in Aqueous Solutions Using Combined Millimeter Wave and Near Infrared Transmission.

Authors:  Helena Cano-Garcia; Rohit Kshirsagar; Roberto Pricci; Ahmed Teyeb; Fergus O'Brien; Shimul Saha; Panagiotis Kosmas; Efthymios Kallos
Journal:  Sensors (Basel)       Date:  2021-05-10       Impact factor: 3.576

9.  Glucose sensing in human epidermis using mid-infrared photoacoustic detection.

Authors:  Jonas Kottmann; Julien M Rey; Joachim Luginbühl; Ernst Reichmann; Markus W Sigrist
Journal:  Biomed Opt Express       Date:  2012-03-01       Impact factor: 3.732

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.